{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T01:01:37Z","timestamp":1773190897113,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.drugpo.2019.09.002","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T05:55:31Z","timestamp":1568872531000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Hepatitis C virus treatment in people who inject drugs (PWID) in Bangladesh"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6876-0191","authenticated-orcid":false,"given":"Mustafizur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5681-719X","authenticated-orcid":false,"given":"Naveed Zafar","family":"Janjua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanveer Khan Ibne","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezazul Islam","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Safiullah","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7319-1333","authenticated-orcid":false,"given":"Sharful Islam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masud","family":"Reza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Omar","family":"Faruque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmedul","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0323-8885","authenticated-orcid":false,"given":"Aslam H.","family":"Anis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasnim","family":"Azim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2019.09.002_bib0001","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.drugpo.2014.09.003","article-title":"Women, drugs and HIV","volume":"26","author":"Azim","year":"2015","journal-title":"International Journal of Drug Policy"},{"issue":"14","key":"10.1016\/j.drugpo.2019.09.002_bib0002","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1080\/10826080802344583","article-title":"Prevalence of infections, HIV risk behaviors and factors associated with HIV infection among male injecting drug users attending a needle\/syringe exchange program in Dhaka, Bangladesh","volume":"43","author":"Azim","year":"2008","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0003","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-7517-2-22","article-title":"Effectiveness of harm reduction programmes for injecting drug users in Dhaka city","volume":"2","author":"Azim","year":"2005","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0004","doi-asserted-by":"crossref","unstructured":"Azim, T., Khan, S.I., Nahar, Q., Reza, M., Alam, N., Saifi, R. et\u00a0al. (2009). 20 years of HIV in Bangladesh: Experiences and way forward. In: World Bank.","DOI":"10.1596\/27592"},{"issue":"1","key":"10.1016\/j.drugpo.2019.09.002_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12954-015-0079-5","article-title":"Drug-related HIV epidemic in Pakistan: A review of current situation and response and the way forward beyond 2015","volume":"12","author":"Bergenstrom","year":"2015","journal-title":"Harm Reduction Journal"},{"issue":"3","key":"10.1016\/j.drugpo.2019.09.002_bib0006","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study","volume":"2","author":"Blach","year":"2017","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0007","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijid.2015.09.011","article-title":"The epidemiology of hepatitis C virus in Afghanistan: Systematic review and meta-analysis","volume":"40","author":"Chemaitelly","year":"2015","journal-title":"International Journal of Infectious Diseases"},{"issue":"5","key":"10.1016\/j.drugpo.2019.09.002_bib0008","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/add.14128","article-title":"Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?","volume":"113","author":"Christensen","year":"2018","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0009","doi-asserted-by":"crossref","unstructured":"Crofts, N., & Azim, T. (2015). Harm reduction in Asia and the Pacific: An evolving public health response. In: BioMed Central.","DOI":"10.1186\/s12954-015-0074-x"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugpo.2018.08.013","article-title":"Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The simplify study","volume":"62","author":"Cunningham","year":"2018","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0011","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/jvh.12055","article-title":"Thermostability of seven hepatitis C virus genotypes in vitro and in vivo","volume":"20","author":"Doerrbecker","year":"2013","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0012","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis C virus infection: A systematic review","volume":"166","author":"Falade-Nwulia","year":"2017","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0013","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.drugpo.2015.05.004","article-title":"Ten priorities for expanding access to HCV treatment for people who inject drugs in low-and middle-income countries","volume":"26","author":"Ford","year":"2015","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0014","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S2468-1253(17)30404-1","article-title":"Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): An open-label, single-arm, phase 4, multicentre trial","volume":"3","author":"Grebely","year":"2018","journal-title":"Lancet Gastroenterology & Hepatology"},{"issue":"1","key":"10.1016\/j.drugpo.2019.09.002_bib0015","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/add.14393","article-title":"Global, regional, and country\u2010level estimates of hepatitis C infection among people who have recently injected drugs","volume":"114","author":"Grebely","year":"2019","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0016","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/cid\/cit377","article-title":"Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: Feasibility and future requirements","volume":"57","author":"Grebely","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"10.1016\/j.drugpo.2019.09.002_bib0017","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2468-1253(18)30304-2","article-title":"Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: A systematic review and meta-analysis","volume":"3","author":"Hajarizadeh","year":"2018","journal-title":"Lancet Gastroenterology & Hepatology"},{"issue":"S1","key":"10.1016\/j.drugpo.2019.09.002_bib0018","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1016\/S0618-8278(19)31466-5","article-title":"Hepatitis C virus reinfection following antiviral treatment among people who inject drugs: A systematic review, meta-analysis, and meta-regression (SAT-233)","volume":"70","author":"Hajarizadeh","year":"2019","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0019","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.drugpo.2015.05.006","article-title":"Hepatitis C transmission and treatment as prevention \u2013 the role of the injecting network","volume":"26","author":"Hellard","year":"2015","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0020","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S2468-1253(16)30182-0","article-title":"Incidence, risk factors, and prevention of hepatitis c reinfection: A population-based cohort study","volume":"2","author":"Islam","year":"2017","journal-title":"Lancet Gastroenterology Hepatology"},{"issue":"4","key":"10.1016\/j.drugpo.2019.09.002_bib0021","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep4.1307","article-title":"Effectiveness of ledipasvir\/sofosbuvir and sofosbuvir\/velpatasvir in people who inject drugs and\/or those in opioid agonist therapy","volume":"3","author":"Janjua","year":"2019","journal-title":"Hepatology Communications"},{"issue":"1","key":"10.1016\/j.drugpo.2019.09.002_bib0022","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5005\/jp-journals-10018-1164","article-title":"Past, present, and future of viral hepatitis in bangladesh","volume":"6","author":"Mahtab","year":"2016","journal-title":"Euroasian Journal of Hepato-Gastroenterology"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0023","first-page":"595","article-title":"Epidemiology of hepatitis B virus in Bangladeshi general population","volume":"7","author":"Mahtab","year":"2008","journal-title":"Hepatobiliary & Pancreatic Diseases International"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0024","unstructured":"NASP. (2011). National HIV serological surveillance, 2011 Bangladesh \u2013 9th Round Technical Report. IEDCR and ICDDR, B (2011) Retrieved February 06, 2013 fromhttp:\/\/aidsdatahub.org\/dmdocuments\/HSS_9th_round_2011.pdf."},{"key":"10.1016\/j.drugpo.2019.09.002_bib0025","unstructured":"NASP. (2016a). Behavioural and serological surveillance amongst key populations at risk of HIV in selected areas of Bangladesh, 2016. In: National AIDS\/STD Program, Directorate General of Health Services, Ministry of Health and Family Welfare, Govt. of Bangladesh. (unpublished)."},{"key":"10.1016\/j.drugpo.2019.09.002_bib0026","unstructured":"NASP. (2016b). Mapping study and size estimations of key populations in Bangladesh for HIV programs 2015-2016. In: National AIDS\/STD Program (NASP), Directorate General of Health Services (DGHS), Ministry of Health and Family Welfare, Govt. of the People's Republic of Bangladesh."},{"key":"10.1016\/j.drugpo.2019.09.002_bib0027","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2018.07.025","article-title":"Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort","volume":"69","author":"Rossi","year":"2018","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0028","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3329\/bmrcb.v35i1.2319","article-title":"Prevalence of hepatitis C virus infection in rural adult population of Bangladesh","volume":"35","author":"Safiullah","year":"2009","journal-title":"Bangladesh Medical Research Council Bulletin"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0029","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/QAD.0b013e32832bd7c9","article-title":"A situation update on HIV epidemics among people who inject drugs and national responses in South-East Asia region","volume":"23","author":"Sharma","year":"2009","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(14)71045-X","article-title":"Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: A cross-sectional study","volume":"15","author":"Solomon","year":"2015","journal-title":"Lancet Infectious Diseases"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0031","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/jac\/dkr215","article-title":"Directly acting antivirals against hepatitis C virus","volume":"66","author":"Soriano","year":"2011","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0032","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/infdis\/jir650","article-title":"Hepatitis C transmission in injection drug users: Could swabs be the main culprit?","volume":"204","author":"Thibault","year":"2011","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0033","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1665-2681(19)31961-1","article-title":"Module l transmission routes of hepatitis C virus infection","volume":"5","author":"Villena","year":"2006","journal-title":"Annals of Hepatology"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0034","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/09540120050123800","article-title":"Measuring medication adherence: Are missed doses reported more accurately then perfect adherence?","volume":"12","author":"Wagner","year":"2000","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugpo.2019.09.002_bib0035","unstructured":"World Health Organization. (2012). WHO, UNODC, unaids technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users\u20132012 revision."}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395919302452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395919302452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:44:09Z","timestamp":1760629449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395919302452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":35,"alternative-id":["S0955395919302452"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2019.09.002","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C virus treatment in people who inject drugs (PWID) in Bangladesh","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2019.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}